Ad is loading...
PEIJX
Price
$45.05
Change
+$0.62 (+1.40%)
Updated
Nov 21 closing price
VVIAX
Price
$69.72
Change
-$0.00 (-0.00%)
Updated
Nov 21 closing price
Ad is loading...

PEIJX vs VVIAX

Header iconPEIJX vs VVIAX Comparison
Open Charts PEIJX vs VVIAXBanner chart's image
Principal Equity Income J
Price$45.05
Change+$0.62 (+1.40%)
VolumeN/A
CapitalizationN/A
Vanguard Value Index Adm
Price$69.72
Change-$0.00 (-0.00%)
VolumeN/A
CapitalizationN/A
PEIJX vs VVIAX Comparison Chart
Loading...
View a ticker or compare two or three
VS
PEIJX vs. VVIAX commentary
Nov 22, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is PEIJX is a Buy and VVIAX is a StrongBuy.

FUNDAMENTALS
Fundamentals
VVIAX has more cash in the bank: 184B vs. PEIJX (9.26B). VVIAX pays higher dividends than PEIJX: VVIAX (2.36) vs PEIJX (1.83). PEIJX was incepted earlier than VVIAX: PEIJX (6 years) vs VVIAX (24 years). PEIJX is a more actively managed with annual turnover of: 13.30 vs. VVIAX (10.00). PEIJX has a lower initial minimum investment than VVIAX: PEIJX (1000) vs VVIAX (3000). PEIJX annual gain was more profitable for investors over the last year : 29.20 vs. VVIAX (26.09). VVIAX return over 5 years is better than : 53.09 vs. PEIJX (42.02).
PEIJXVVIAXPEIJX / VVIAX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence6 years24 years-
Gain YTD21.33519.672108%
Front LoadN/AN/A-
Min. Initial Investment1000300033%
Min. Initial Investment IRAN/AN/A-
Net Assets9.26B184B5%
Annual Yield % from dividends1.832.3678%
Returns for 1 year29.2026.09112%
Returns for 3 years10.9724.7744%
Returns for 5 years42.0253.0979%
Returns for 10 yearsN/A112.26-
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
DOLE15.260.19
+1.26%
Dole plc
NCNO40.450.37
+0.92%
nCino
SGHT3.760.03
+0.80%
Sight Sciences
VICI32.370.25
+0.78%
VICI Properties
SABS3.070.01
+0.33%
SAB Biotherapeutics